ZUCCONI THEODORE DANIEL 4
4 · GALECTIN THERAPEUTICS INC · Filed Apr 18, 2018
Insider Transaction Report
Form 4
ZUCCONI THEODORE DANIEL
DirectorCEO and President
Transactions
- Exercise/Conversion
Stock option (right to buy)
2018-04-16−4,000→ 27,250 totalExercise: $0.89Exp: 2026-12-15→ Common stock (4,000 underlying) - Exercise/Conversion
Common Stock
2018-04-16$0.89/sh+4,000$3,560→ 5,083 total - Sale
Common Stock
2018-04-16$3.58/sh−4,000$14,320→ 1,083 total
Footnotes (1)
- [F1]The options vested 100% on the date of Galectin Therapeutics, Inc.'s 2017 Annual Stockholders Meeting.